Avet Lifesciences Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AVET LIFESCIENCES
AVET LIFESCIENCES has thirty-nine approved drugs.
Summary for Avet Lifesciences
| US Patents: | 0 |
| Tradenames: | 34 |
| Ingredients: | 33 |
| NDAs: | 39 |
Drugs and US Patents for Avet Lifesciences
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avet Lifesciences | PROPOFOL | propofol | INJECTABLE;INJECTION | 206408-001 | Oct 12, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Avet Lifesciences | PROCHLORPERAZINE EDISYLATE | prochlorperazine edisylate | INJECTABLE;INJECTION | 204147-001 | Oct 15, 2013 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Avet Lifesciences | ACETAZOLAMIDE SODIUM | acetazolamide sodium | INJECTABLE;INJECTION | 202693-001 | Dec 19, 2014 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
